HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX)
CUSIP: 427746102
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 182,615,507
- Total 13F shares
- 108,488,554
- Share change
- +4,608,486
- Total reported value
- $1,160,926,758
- Put/Call ratio
- 58%
- Price per share
- $10.69
- Number of holders
- 189
- Value change
- +$41,634,303
- Number of buys
- 92
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 427746102:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13F
|
Company |
7.3%
|
13,268,720
|
$205,930,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.1%
|
9,319,728
|
$144,643,000 | — | 30 Jun 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4.5%
|
8,131,678
|
$126,204,000 | — | 30 Jun 2021 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.3%
|
7,907,087
|
$122,718,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
7,521,849
|
$116,740,000 | — | 30 Jun 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
3.2%
|
5,903,968
|
$91,630,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
4,712,719
|
$73,141,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.5%
|
4,510,102
|
$69,997,000 | — | 30 Jun 2021 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
2.4%
|
4,425,000
|
$68,676,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.3%
|
4,221,689
|
$65,521,000 | — | 30 Jun 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.2%
|
2,199,057
|
$34,129,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
1,964,150
|
$30,483,000 | — | 30 Jun 2021 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
1%
|
1,819,131
|
$28,233,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.94%
|
1,714,290
|
$26,606,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
1,589,392
|
$24,667,000 | — | 30 Jun 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
1,490,440
|
$23,132,000 | — | 30 Jun 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.8%
|
1,467,675
|
$22,778,000 | — | 30 Jun 2021 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.66%
|
1,202,069
|
$18,656,000 | — | 30 Jun 2021 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.61%
|
1,113,793
|
$17,286,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
961,953
|
$14,930,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
824,313
|
$12,793,000 | — | 30 Jun 2021 | |
| Pekin Hardy Strauss, Inc. |
13F
|
Company |
0.43%
|
776,700
|
$12,054,000 | — | 30 Jun 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.42%
|
758,570
|
$11,773,000 | — | 30 Jun 2021 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.4%
|
722,978
|
$11,221,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
692,966
|
$10,755,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.35%
|
637,446
|
$9,894,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
0.35%
|
630,983
|
$9,793,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
628,345
|
$9,752,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.33%
|
599,865
|
$9,310,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.29%
|
520,685
|
$8,081,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
520,398
|
$8,077,000 | — | 30 Jun 2021 | |
| NEXPOINT ASSET MANAGEMENT, L.P. |
13F
|
Company |
0.27%
|
499,131
|
$7,747,000 | — | 30 Jun 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
496,416
|
$7,704,000 | — | 30 Jun 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.21%
|
391,433
|
$6,075,000 | — | 30 Jun 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.21%
|
380,242
|
$5,901,000 | — | 30 Jun 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.21%
|
379,899
|
$5,896,000 | — | 30 Jun 2021 | |
| KETTLE HILL CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
372,199
|
$5,777,000 | — | 30 Jun 2021 | |
| Orchard Capital Management, LLC |
13F
|
Company |
0.2%
|
358,904
|
$5,570,000 | — | 30 Jun 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.19%
|
350,109
|
$5,560,000 | — | 30 Jun 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.19%
|
351,011
|
$5,489,000 | — | 30 Jun 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.18%
|
329,663
|
$5,116,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
327,721
|
$5,086,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
299,586
|
$4,649,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.16%
|
297,277
|
$4,614,000 | — | 30 Jun 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.16%
|
295,276
|
$4,583,000 | — | 30 Jun 2021 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.14%
|
260,919
|
$4,049,000 | — | 30 Jun 2021 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.13%
|
244,793
|
$3,800,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.13%
|
243,449
|
$3,778,000 | — | 30 Jun 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
211,859
|
$3,288,000 | — | 30 Jun 2021 | |
| Congress Park Capital LLC |
13F
|
Company |
0.11%
|
196,487
|
$3,049,000 | — | 30 Jun 2021 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q3 2021
As of 30 Sep 2021,
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,488,554 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., UBS OCONNOR LLC, STATE STREET CORP, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, and PFM Health Sciences, LP.
This page lists
189
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
182
Q3 2021 holders
189
Holder diff
7
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.